U.S. RESEARCH ROUNDUP-Aramark, Mirati Therapeutics, UnitedHealth Group

Core Laboratories

09/10/2023 08:23

Oct 9 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Aramark, Mirati Therapeutics, and
UnitedHealth Group on Monday. 
     
    HIGHLIGHTS
                 * Aramark  ARMK.N : Jefferies raises to buy from hold; cuts target price to $29 from $44 
 
                 * Mirati Therapeutics Inc  MRTX.O : Jefferies cuts to hold from buy
 
                 * UnitedHealth Group Inc  UNH.N : Jefferies raises target price to $531 from $529 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
    
                 * Accolade Inc  ACCD.O : Piper Sandler cuts target price to $15 from $16.5 
 
                 * Amgen Inc  AMGN.O : Oppenheimer raises target price to $290 from $280 
 
                 * Aramark  ARMK.N : Jefferies raises to buy from hold; cuts target price to $29 from $44 
 
                 * ARM Holdings Plc  ARM.O : JP Morgan initiates coverage with overweight rating and $70 PT
 
                 * ARM Holdings Plc  ARM.O : TD Cowen initiates coverage with outperform rating and $63 PT 
 
                 * Biohaven Ltd  BHVN.N : Leerink Partners raises target price to $28 from $23 
 
                 * Centene Corp  CNC.N : Jefferies cuts target price to $81 from $82 
 
                 * Championx Corp  CHX.O : TD Cowen raises target price to $41 from $40 
 
                 * Core Laboratories Inc  CLB.N : TD Cowen cuts target price to $18 from $19 
 
                 * Darling Ingredients Inc  DAR.N : Jefferies cuts target price to $81 from $85 
 
                 * Dril-Quip Inc  DRQ.N : TD Cowen cuts target price to $25 from $26 
 
                 * Ford Motor Co  F.N : Jefferies cuts target price to $13.5 from $15 
 
                 * General Motors Co  GM.N : Jefferies cuts target price to $35 from $39 
 
                 * Humana Inc  HUM.N : Jefferies raises target price to $586 from $580 
 
                 * Jack In the Box Inc  JACK.O : Piper Sandler cuts target price to $75 from $93 
 
                 * Mastercard Inc  MA.N : JP Morgan cuts target price to $496 from $510 
 
                 * Mirati Therapeutics Inc  MRTX.O : Jefferies cuts to hold from buy
 
                 * Mirati Therapeutics Inc  MRTX.O : Jefferies raises target price to $58 from $55 
 
                 * Mirati Therapeutics Inc  MRTX.O : Jonestrading cuts to hold 
 
                 * Mirati Therapeutics Inc  MRTX.O : Jonestrading raises target price to $58 
 
                 * Nuvalent Inc  NUVL.O : Piper Sandler raises target price to $70 from $54 
 
                 * UnitedHealth Group Inc  UNH.N : Jefferies raises target price to $531 from $529 
 
                 * Visa Inc  V.N : JP Morgan cuts target price to $293 from $296 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))